Atai Life Sciences Ownership | Who Owns Atai Life Sciences?

Overview Forecast RevenueFinancials Chart

Atai Life Sciences Ownership Summary

Atai Life Sciences is owned by 7.54% institutional investors, 9.99% insiders, and 82.47% retail investors. Walleye capital is the largest institutional shareholder, holding 1.74% of ATAI shares. iShares Biotechnology ETF is the top mutual fund, with 0.47% of its assets in Atai Life Sciences shares.

ATAI Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Atai Life Sciences	7.54%	9.99%	82.47%
Sector	Healthcare Stocks	47.31%	8.01%	44.69%
Industry	Biotech Stocks	45.43%	7.81%	46.75%
Idea	Psychedelic Stocks List	21.38%	11.18%	67.44%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Walleye capital	2.76M	1.74%	$3.67M
Morgan stanley	2.72M	1.71%	$3.62M
Blackrock	1.31M	0.82%	$1.74M
Brown university	718.50K	0.45%	$955.61K
Two sigma investments, lp	717.13K	0.45%	$953.78K
Millennium management	648.19K	0.41%	$862.09K
Vanguard group	411.48K	0.26%	$547.27K
Franklin resources	356.36K	0.22%	$473.95K
Barclays	245.72K	0.15%	$327.00K
Advisorshares investments	200.83K	0.13%	$271.12K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Brown university	718.50K	0.36%	$955.61K
Hyperion capital advisors lp	168.42K	0.11%	$223.99K
Objectivity squared	45.21K	0.06%	$74.14K
Advisorshares investments	200.83K	0.05%	$271.12K
Audent global asset management	16.84K	0.02%	$22.39K
Walleye capital	2.76M	0.01%	$3.67M
Resolute advisors	16.78K	0.01%	$22.31K
Hunter perkins capital management	17.24K	0.00%	$23.00K
Gould capital	5.00K	0.00%	$6.65K
Detalus advisors	10.00K	0.00%	$13.30K

Top Buyers

Holder	Shares	% Assets	Change
Walleye capital	2.76M	0.01%	2.66M
Two sigma investments, lp	717.13K	0.00%	316.15K
Morgan stanley	2.72M	0.00%	50.90K
Sg americas securities	48.94K	0.00%	48.94K
Virtu financial	46.95K	0.00%	46.95K

Top Sellers

Holder	Shares	% Assets	Change
Millennium management	648.19K	0.00%	-1.57M
Marshall wace, llp	-	-	-793.84K
Citadel advisors	3.08K	-	-304.74K
Tejara capital	-	-	-260.21K
Xtx topco	-	-	-184.61K

New Positions

Holder	Shares	% Assets	Change	Value
Sg americas securities	48.94K	0.00%	48.94K	$65.00K
Wedmont private capital	25.00K	0.00%	25.00K	$38.50K
Pale fire capital se	24.78K	0.00%	24.78K	$32.96K
Cambridge investment research advisors	13.67K	0.00%	13.67K	$18.00K
Raymond james financial services advisors	12.95K	-	12.95K	$17.22K

Sold Out

Holder	Change
Redwood wealth management group	-200.00
Legend financial advisors	-233.00
Venturi wealth management	-300.00
Cwm	-350.00
Cornerstone planning group	-400.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	90	-	11,979,202	-3.00%	7	12.47%	31	6.90%	15	-25.00%
Mar 31, 2024	90	3.45%	12,349,507	-6.74%	7	10.76%	29	-17.14%	20	-
Dec 31, 2023	87	-9.38%	13,241,539	-8.77%	8	9.79%	35	29.63%	20	-25.93%
Sep 30, 2023	96	-2.04%	14,514,979	-4.19%	9	9.85%	27	-25.00%	27	12.50%
Jun 30, 2023	98	-7.55%	15,150,149	-11.37%	9	8.08%	36	-23.40%	24	-11.11%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Biotechnology ETF	794.76K	0.47%	-4.75K
Morgan Stanley Inception	525.91K	0.31%	-26.46K
Morgan Stanley Inst Inception I	525.91K	0.31%	-26.46K
Horizons Psychedelic Stock ETF	520.20K	0.31%	-82.78K
Kieger Impact Healthcare A USD Acc	438.30K	0.26%	-
Vanguard Health Care ETF	406.59K	0.24%	-1.10K
EQ/Morgan Stanley Small Cap Growth K	316.73K	0.19%	-
AdvisorShares Psychedelics ETF	280.37K	0.17%	-
iShares Healthcare Innov ETF USD Acc	244.05K	0.15%	-
Kairos Intl SICAV Opports L/S P	212.70K	0.13%	212.70K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 16, 2024	Brand Florian	See Remarks	Sell	$290.50K
Apr 02, 2024	Johnson Anne Nagengast	Chief Financial Officer	Sell	$50.71K
Apr 02, 2024	Rao Srinivas	See Remarks	Sell	$114.03K
Apr 02, 2024	Kirpekar Sahil	Chief Business Officer	Sell	$66.23K
Nov 16, 2023	Brand Florian	See Remarks	Buy	$23.12K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q2	-	4
2024 Q1	-	-
2023 Q4	1	-
2023 Q3	1	-

ATAI Ownership FAQ

Who Owns Atai Life Sciences?

Atai Life Sciences shareholders are primarily institutional investors at 7.54%, followed by 9.99% insiders and 82.47% retail investors. The average institutional ownership in Atai Life Sciences's industry, Biotech Stocks , is 45.43%, which Atai Life Sciences falls below.

Who owns the most shares of Atai Life Sciences?

Atai Life Sciences’s largest shareholders are Walleye capital (2.76M shares, 1.74%), Morgan stanley (2.72M shares, 1.71%), and Blackrock (1.31M shares, 0.82%). Together, they hold 4.27% of Atai Life Sciences’s total shares outstanding.

Does Blackrock own Atai Life Sciences?

Yes, BlackRock owns 0.82% of Atai Life Sciences, totaling 1.31M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.74M$. In the last quarter, BlackRock decreased its holdings by -94.533K shares, a -6.75% change.

Who is Atai Life Sciences’s biggest shareholder by percentage of total assets invested?

Brown university is Atai Life Sciences’s biggest shareholder by percentage of total assets invested, with 0.36% of its assets in 718.5K Atai Life Sciences shares, valued at 955.6K$.

Who is the top mutual fund holder of Atai Life Sciences shares?

iShares Biotechnology ETF is the top mutual fund holder of Atai Life Sciences shares, with 0.47% of its total shares outstanding invested in 794.76K Atai Life Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools